Explore the competition between Recursive and Ricursive startups in Silicon Valley aiming to build AI systems that ...

Tempus AI's diagnostics segment shows strong pricing power, with Oncology ASP rising from $1,630 to over $2,200. Read why TEM ...

Some AI-focused companies are not worth the trouble.